Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COMy Virtual 2020 | Primary and secondary plasma cell leukemia

Artur Jurczyszyn • 11 May 2020
COMy Virtual 2020
Leukemia

Artur Jurczyszyn, MD, PhD, Jagiellonian University Medical College, Kraków, Poland, discusses updates in plasma cell leukemia in 2020. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Artur Jurczyszyn

2:20
Aims & projects of the Myeloma Treatment Foundation Centre in Poland
Artur Jurczyszyn • 26 Aug 2022
1:21
The impact of physical activity in patients with multiple myeloma
Artur Jurczyszyn • 26 Aug 2022
1:25
The importance of early treatment in MGRS & the role of the MDT
Artur Jurczyszyn • 26 Aug 2022
1:13
The importance of bone disease control in multiple myeloma
Artur Jurczyszyn • 26 Aug 2022

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals